Browse Brief: Harold Burstein, MD, PhD, and Sarah Sammons, MD, discuss the DESTINYBreast09, HER2-CLIMB, and PATINA CNS trials for ... Antonio Llombart-Cussac, MD, PhD, Hospital Arnau de Vilanova, Valencia, Spain, shares his

Highlights From Sabcs 2023 - Information Complete Overview

This page organizes Highlights From Sabcs 2023 with quick summaries, related pages, and practical search paths in a simple and scannable format.

In addition, this page also connects Highlights From Sabcs 2023 with for broader topic coverage.

Information Complete Overview

Paolo Tarantino, MD, Dana-Farber Cancer Institute, Boston, MA, shares his Harold Burstein, MD, PhD, and Ilana Schlam, MD, MPH, discuss important advances in ctDNA and minimal residual disease ...

Topic Why It Matters

Adam Brufsky, MD, PhD, University of Pittsburgh, Pittsburgh, PA, shares what he is looking forward to most at the San Antonio ... Harold Burstein, MD, PhD, and Sarah Sammons, MD, discuss the DESTINYBreast09, HER2-CLIMB, and PATINA CNS trials for ... Jason Aboudi Mouabbi, MD, from the University of Texas MD Anderson Cancer Center, shares insights from the San Antonio ...

Guide Reference Notes

Jason Aboudi Mouabbi, MD, from the University of Texas MD Anderson Cancer Center, shares insights from the San Antonio ... Kelly-Anne Phillips, MBBS (Hons), MD, FRACP, FAHMS, Peter MacCallum Cancer Center, Melbourne, Australia, gives her ...

Reference Before You Decide

Antonio Llombart-Cussac, MD, PhD, Hospital Arnau de Vilanova, Valencia, Spain, shares his Prashanth Ashok Kumar, MD, Upstate University Hospital, Syracuse, NY, shares his Nadia Harbeck, MD, PhD, LMU Munich, Munich, Germany, discussing ongoing breast cancer clinical trials, including the ADAPT ...

Main details to review

  • Jason Aboudi Mouabbi, MD, from the University of Texas MD Anderson Cancer Center, shares insights from the San Antonio ...
  • Adam Brufsky, MD, PhD, University of Pittsburgh, Pittsburgh, PA, shares what he is looking forward to most at the San Antonio ...
  • Nadia Harbeck, MD, PhD, LMU Munich, Munich, Germany, discussing ongoing breast cancer clinical trials, including the ADAPT ...
  • Kalinsky, MD, MS, from the Winship Cancer Institute in Atlanta, GA, discusses exciting posters presented during the ...

How this reference can help

A structured page helps by giving readers practical reminders for Highlights From Sabcs 2023 before choosing what to open next.

Sponsored

Reader Questions

What is the safest way to use Highlights From Sabcs 2023 information?

Use it as general context first, then verify important points with official, primary, or more specific sources when accuracy matters.

How does Highlights From Sabcs 2023 connect to topic?

Highlights From Sabcs 2023 can connect to topic when readers need context, examples, comparisons, or practical next steps inside the same topic area.

How does Highlights From Sabcs 2023 connect to overview?

Highlights From Sabcs 2023 can connect to overview when readers need context, examples, comparisons, or practical next steps inside the same topic area.

Visual Discovery Notes

Highlights from SABCS 2023: novel agents and insights on HER2 dynamics in breast cancer
Highlights from SABCS 2023
Highlights from SABCS 2023: recognition for breast cancer prevention
2025 SABCS Highlights: Advances in ctDNA for Breast Cancer | Dana-Farber Cancer Institute
2025 SABCS Highlights: First-Line Tx for HER2+ Advanced Breast Cancer | Dana-Farber Cancer Institute
Highlights from SABCS 2020
SABCS 2023 highlights: PARSIFAL-LONG, MONARCH 3, KATHERINE
SABCS 2022 highlights
Key highlights from SABCS 2022
SABCS 2022 highlights
Sponsored
Open Search Result
Highlights from SABCS 2023: novel agents and insights on HER2 dynamics in breast cancer

Highlights from SABCS 2023: novel agents and insights on HER2 dynamics in breast cancer

Kevin M. Kalinsky, MD, MS, from the Winship Cancer Institute in Atlanta, GA, discusses exciting posters presented during the ...

Highlights from SABCS 2023

Highlights from SABCS 2023

Jason Aboudi Mouabbi, MD, from the University of Texas MD Anderson Cancer Center, shares insights from the San Antonio ...

Highlights from SABCS 2023: recognition for breast cancer prevention

Highlights from SABCS 2023: recognition for breast cancer prevention

Kelly-Anne Phillips, MBBS (Hons), MD, FRACP, FAHMS, Peter MacCallum Cancer Center, Melbourne, Australia, gives her ...

2025 SABCS Highlights: Advances in ctDNA for Breast Cancer | Dana-Farber Cancer Institute

2025 SABCS Highlights: Advances in ctDNA for Breast Cancer | Dana-Farber Cancer Institute

Harold Burstein, MD, PhD, and Ilana Schlam, MD, MPH, discuss important advances in ctDNA and minimal residual disease ...

2025 SABCS Highlights: First-Line Tx for HER2+ Advanced Breast Cancer | Dana-Farber Cancer Institute

2025 SABCS Highlights: First-Line Tx for HER2+ Advanced Breast Cancer | Dana-Farber Cancer Institute

Harold Burstein, MD, PhD, and Sarah Sammons, MD, discuss the DESTINYBreast09, HER2-CLIMB, and PATINA CNS trials for ...

Highlights from SABCS 2020

Highlights from SABCS 2020

Nadia Harbeck, MD, PhD, LMU Munich, Munich, Germany, discussing ongoing breast cancer clinical trials, including the ADAPT ...

SABCS 2023 highlights: PARSIFAL-LONG, MONARCH 3, KATHERINE

SABCS 2023 highlights: PARSIFAL-LONG, MONARCH 3, KATHERINE

Antonio Llombart-Cussac, MD, PhD, Hospital Arnau de Vilanova, Valencia, Spain, shares his

SABCS 2022 highlights

SABCS 2022 highlights

Paolo Tarantino, MD, Dana-Farber Cancer Institute, Boston, MA, shares his

Key highlights from SABCS 2022

Key highlights from SABCS 2022

Prashanth Ashok Kumar, MD, Upstate University Hospital, Syracuse, NY, shares his

SABCS 2022 highlights

SABCS 2022 highlights

Adam Brufsky, MD, PhD, University of Pittsburgh, Pittsburgh, PA, shares what he is looking forward to most at the San Antonio ...